Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double‐Blind, Placebo‐Controlled Study

Gretchen Hermes; Scott M. Hyman; Nia Fogelman; Thomas R. Kosten; Rajita Sinha

doi:10.1111/ajad.12942

Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double‐Blind, Placebo‐Controlled Study

American Journal on Addictions ◽

10.1111/ajad.12942 ◽

2019 ◽

Vol 28 (6) ◽

pp. 480-488

Author(s):

Gretchen Hermes ◽

Scott M. Hyman ◽

Nia Fogelman ◽

Thomas R. Kosten ◽

Rajita Sinha

Keyword(s):

Relapse Prevention ◽

Opioid Use Disorder ◽

Controlled Study ◽

Opioid Use ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Naltrexone

Download Full-text

480: Intraoperative Port Site Infiltration with Bupivicaine Reduces Post Operative Parenteral Opioid Use in Laparoscopic Urologic Surgery: A Randomized, Double Blind, Placebo Controlled Study

The Journal of Urology ◽

10.1016/s0022-5347(18)37742-5 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 128-128

Author(s):

Herkanwal S. Khaira ◽

J. Stuart Wolf

Keyword(s):

Port Site ◽

Controlled Study ◽

Opioid Use ◽

Double Blind ◽

Double Blind Placebo ◽

Urologic Surgery

Download Full-text

Relapse Prevention in Pediatric Patients With ADHD Treated With Atom-oxetine: A Randomized, Double-Blind, Placebo-Controlled Study

Yearbook of Pediatrics ◽

10.1016/s0084-3954(07)70073-8 ◽

2006 ◽

Vol 2006 ◽

pp. 92-93

Author(s):

J.A. Stockman

Keyword(s):

Relapse Prevention ◽

Pediatric Patients ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of a Monthly Buprenorphine Depot Injection for Opioid Use Disorder: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3228895 ◽

2018 ◽

Author(s):

Barbara R. Haight ◽

Susan M. Learned ◽

Celine M. Laffont ◽

Paul J. Fudala ◽

Yue Zhao ◽

...

Keyword(s):

Controlled Trial ◽

Opioid Use Disorder ◽

Efficacy And Safety ◽

Opioid Use ◽

Double Blind ◽

Double Blind Placebo ◽

Depot Injection

Download Full-text

P03-359 Randomized, double-blind, placebo-controlled study of risperidone long-acting injectable in relapse prevention in patients with bipolar I disorder

European Psychiatry ◽

10.1016/s0924-9338(10)70965-2 ◽

2010 ◽

Vol 25 ◽

pp. 974 ◽

Cited By ~ 1

Author(s):

S. Montgomery ◽

E. Vieta ◽

A.H. Sulaiman ◽

R. Cordoba ◽

B. Huberlant ◽

...

Keyword(s):

Relapse Prevention ◽

Controlled Study ◽

Double Blind ◽

Bipolar I Disorder ◽

Double Blind Placebo ◽

Long Acting

Download Full-text

Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2009.03129.x ◽

2009 ◽

Vol 23 (8) ◽

pp. 948-950 ◽

Cited By ~ 28

Author(s):

F Malekzad ◽

M Arbabi ◽

N Mohtasham ◽

P Toosi ◽

M Jaberian ◽

...

Keyword(s):

Atopic Eczema ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Naltrexone

Download Full-text

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study

Journal of Hepatology ◽

10.1016/s0168-8278(02)00318-5 ◽

2002 ◽

Vol 37 (6) ◽

pp. 717-722 ◽

Cited By ~ 106

Author(s):

Rubén Terg ◽

Emma Coronel ◽

Juan Sordá ◽

Alberto E Muñoz ◽

Jorge Findor

Keyword(s):

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Naltrexone ◽

Naltrexone Treatment

Download Full-text

Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study

Depression and Anxiety ◽

10.1002/da.22872 ◽

2019 ◽

Vol 36 (3) ◽

pp. 225-234

Author(s):

Suresh Durgam ◽

Changzheng Chen ◽

Raffaele Migliore ◽

Chandran Prakash ◽

Michael E. Thase

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Relapse Prevention ◽

Controlled Study ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2555960.2208061 ◽

2010 ◽

Author(s):

Hidehisa Saeki

Keyword(s):

Atopic Eczema ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Naltrexone

Download Full-text

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet ◽

10.1016/s0140-6736(18)32259-1 ◽

2019 ◽

Vol 393 (10173) ◽

pp. 778-790 ◽

Cited By ~ 54

Author(s):

Barbara R Haight ◽

Susan M Learned ◽

Celine M Laffont ◽

Paul J Fudala ◽

Yue Zhao ◽

...

Keyword(s):

Opioid Use Disorder ◽

Efficacy And Safety ◽

Opioid Use ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Depot Injection

Download Full-text

Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment

Addiction ◽

10.1111/add.13259 ◽

2016 ◽

Vol 111 (5) ◽

pp. 874-882 ◽

Cited By ~ 12

Author(s):

Azarakhsh Mokri ◽

Marek C. Chawarski ◽

Hamidreza Taherinakhost ◽

Richard S. Schottenfeld

Keyword(s):

Maintenance Treatment ◽

Opioid Use Disorder ◽

Opioid Use ◽

Double Blind ◽

Medical Treatments ◽

Double Blind Placebo

Download Full-text